We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Pharmacokinetic profile of children with haemophilia A receiving low‐dose FVIII prophylaxis in Indonesia: A single centre experience.
- Authors
Primacakti, Fitri; Sari, Teny T.; Gatot, Djajadiman; Sjakti, Hikari A.; Chozie, Novie A.
- Abstract
Background: Pharmacokinetic (PK) studies of low‐dose prophylaxis (LDP) of coagulation factor VIII (FVIII) in children with severe haemophilia A (SHA) are scarce. Objective: This study aims to investigate the PK profile of children with SHA receiving LDP of FVIII. Methods: Paediatric patients receiving FVIII infusions (10 IU/kg twice weekly) were included. PK profiles were estimated using the Web Accessible Population Pharmacokinetic Service for Haemophilia (WAPPS‐Haemo). The primary outcomes were the terminal half‐life (t1/2), concentration–time profile, and time to reach an FVIII level of < 1%. The secondary outcome was the suggested dosing interval of FVIII prophylaxis based on the individual PK profile. Results: Twenty‐five patients were recruited; their mean age was 12.3 ± 3.0 years. The t1/2 differed among patients receiving LDP of FVIII twice weekly, with a median of t1/2 was 14.8 h (IQR 12.6–16). The median time to reach an FVIII level of < 1% was 73.8 h (IQR 58.8–80.3). Most patients could maintain a trough level of FVIII > 1% longer than 48 h. At 72–96 h, patients needed a second dose of FVIII infusion because the FVIII level was < 1%. The suggested dosing interval of FVIII prophylaxis ranged from daily to every 96 h, depending on the individual PK profile. Conclusion: Our study identified inter‐individual differences in the PK parameters using LDP of FVIII twice weekly. The inter‐individual results in different dosing intervals advise the timing of LDP. Estimating individual PK parameters enables the identification of the optimal prophylaxis frequency to prevent bleedings.
- Subjects
INDONESIA; HEMOPHILIACS; PHARMACOKINETICS; CHILD patients; HEMOPHILIA; BLOOD coagulation factor VIII; BLOOD coagulation factors
- Publication
Haemophilia, 2022, Vol 28, Issue 5, p720
- ISSN
1351-8216
- Publication type
Article
- DOI
10.1111/hae.14584